Marilyn S. Albert

Marilyn S. Albert's AcademicInfluence.com Rankings

Marilyn S. Albert

Philosophy

#3972

World Rank

#6322

Historical Rank

Ontology

#24

World Rank

#29

Historical Rank

Logic

#1537

World Rank

#2314

Historical Rank

philosophy Degrees

Marilyn S. Albert

Biology

#5092

World Rank

#7488

Historical Rank

Neuroscience

#563

World Rank

#586

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Marilyn S. Albert's Degrees

PhD Neuroscience University of California, Berkeley
Doctorate Medicine University of California, San Francisco

Why Is Marilyn S. Albert Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Marilyn S. Albert's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest (2006) (9145)
Whole Brain Segmentation Automated Labeling of Neuroanatomical Structures in the Human Brain (2002) (7189)
The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease (2011) (6818)
The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods (2008) (2996)
Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. (1989) (1992)
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (2011) (1680)
Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. (2001) (1424)
Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer (2006) (1371)
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
Social relationships, social support, and patterns of cognitive aging in healthy, high-functioning older adults: MacArthur studies of successful aging. (2001) (782)
Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD (2005) (765)
Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis (2016) (716)
Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment (2012) (701)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
Alpha-2 macroglobulin is genetically associated with Alzheimer disease (1998) (665)
Alterations in Memory Networks in Mild Cognitive Impairment and Alzheimer's Disease: An Independent Component Analysis (2006) (638)
Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain (2004) (635)
Conscious recollection and the human hippocampal formation: evidence from positron emission tomography. (1996) (589)
Predictors of cognitive change in older persons: MacArthur studies of successful aging. (1995) (539)
Maintenance, reserve and compensation: the cognitive neuroscience of healthy ageing (2018) (539)
Predicting changes in physical performance in a high-functioning elderly cohort: MacArthur studies of successful aging. (1994) (536)
MRI measures of entorhinal cortex vs hippocampus in preclinical AD (2002) (536)
High, usual and impaired functioning in community-dwelling older men and women: findings from the MacArthur Foundation Research Network on Successful Aging. (1993) (525)
Preclinical prediction of AD using neuropsychological tests (2001) (519)
MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths (2009) (515)
Incidence and Predictors of Seizures in Patients with Alzheimer's Disease (2006) (509)
Preclinical prediction of Alzheimer's disease using SPECT (1998) (499)
Medial temporal lobe function and structure in mild cognitive impairment (2004) (498)
ApoE-4 and Age at Onset of Alzheimer's Disease (1997) (494)
Age-specific incidence of Alzheimer's disease in a community population. (1995) (486)
Interleukin-6 and risk of cognitive decline: MacArthur Studies of Successful Aging (2002) (486)
Pattern separation deficits associated with increased hippocampal CA3 and dentate gyrus activity in nondemented older adults (2010) (467)
Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. (1991) (447)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging and Alzheimer's Association workgroup (2011) (441)
Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: Application to normal elderly and Alzheimer's disease participants (2009) (438)
Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. (1997) (435)
White matter changes with normal aging (1998) (429)
fMRI studies of associative encoding in young and elderly controls and mild Alzheimer’s disease (2003) (425)
High-resolution structural and functional MRI of hippocampal CA3 and dentate gyrus in patients with amnestic Mild Cognitive Impairment (2010) (411)
Increase in urinary cortisol excretion and memory declines: MacArthur studies of successful aging. (1997) (394)
Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. (1993) (394)
Results of a high-resolution genome screen of 437 Alzheimer's disease families. (2003) (362)
Predicting conversion to Alzheimer disease using standardized clinical information. (2000) (355)
Putting names to faces: Successful encoding of associative memories activates the anterior hippocampal formation (2003) (355)
Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort (2017) (349)
Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study. (2014) (348)
Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome. (1986) (348)
Predicting time to nursing home care and death in individuals with Alzheimer disease. (1997) (346)
The course of psychopathologic features in mild to moderate Alzheimer disease. (1997) (338)
Temporal gradients in the retrograde amnesia of patients with alcoholic Korsakoff's disease. (1979) (334)
The NIH Cognitive and Emotional Health Project Report of the Critical Evaluation Study Committee (2006) (327)
Level of education and change in cognitive function in a community population of older persons. (1993) (314)
Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis (2012) (308)
Achieving and maintaining cognitive vitality with aging. (2002) (306)
Behavioral and psychosocial predictors of physical performance: MacArthur studies of successful aging. (1995) (301)
Delusions and hallucinations are associated with worse outcome in Alzheimer disease. (2005) (296)
Neurobiological Bases of Age-Related Cognitive Decline in the Rhesus Monkey (1996) (288)
Performance-based driving evaluation of the elderly driver: safety, reliability, and validity. (1994) (287)
Executive function deficits in mild Alzheimer's disease. (1995) (279)
Detection of cortical thickness correlates of cognitive performance: Reliability across MRI scan sessions, scanners, and field strengths (2008) (275)
Age at onset of Alzheimer's disease (1994) (266)
The Test for Severe Impairment: An Instrument for the Assessment of Patients with Severe Cognitive Dysfunction (1992) (262)
Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative. (1994) (261)
Diabetes in Midlife and Cognitive Change Over 20 Years (2014) (258)
Age‐related differences in brain electrical activity of healthy subjects (1984) (253)
Neuropsychological measures in normal individuals that predict subsequent cognitive decline. (2007) (252)
Seizures in Alzheimer disease: who, when, and how common? (2009) (250)
Cognitive and neurobiologic markers of early Alzheimer disease. (1996) (241)
Correlates of cognitive function in an elderly community population. (1988) (236)
Hearing loss and dementia – who is listening? (2014) (235)
Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease (1994) (234)
Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease (2009) (221)
The role of hippocampus and frontal cortex in age‐ related memory changes: a PET study (1996) (217)
Motor signs during the course of Alzheimer disease (2004) (216)
Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. (2008) (211)
Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance (2015) (208)
Correlations between MRI white matter lesion location and executive function and episodic memory (2011) (203)
Impaired Awareness of Deficits in Alzheimer Disease (1996) (202)
Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. (1997) (201)
Selectivity of executive function deficits in mild cognitive impairment. (2009) (200)
Quality of Life in Patients with Alzheimer's Disease as Reported by Patient Proxies (1996) (200)
Functional MRI detection of pharmacologically induced memory impairment (2001) (195)
Spatial Distribution of White-Matter Hyperintensities in Alzheimer Disease, Cerebral Amyloid Angiopathy, and Healthy Aging (2008) (194)
Multi-contrast large deformation diffeomorphic metric mapping for diffusion tensor imaging (2009) (190)
Motor signs predict poor outcomes in Alzheimer disease (2005) (189)
Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau (2018) (186)
Association of Midlife to Late-Life Blood Pressure Patterns With Incident Dementia. (2019) (185)
APOE ε4 allele predicts faster cognitive decline in mild Alzheimer disease (2008) (185)
The Use of Body Movements and Gestures as Cues to Emotions in Younger and Older Adults (1999) (181)
Changes in naming ability with age. (1988) (180)
Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer’s disease (2012) (176)
Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease. (2016) (172)
Why has therapy development for dementia failed in the last two decades? (2016) (165)
Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment. (2007) (164)
Hearing impairment and cognitive decline: a pilot study conducted within the atherosclerosis risk in communities neurocognitive study. (2015) (160)
Mild cognitive impairment and dementia prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study (2016) (159)
Assessing patient dependence in Alzheimer's disease. (1994) (159)
GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease (2016) (157)
Longitudinal change in cognitive performance among individuals with mild cognitive impairment. (2007) (155)
Neuropsychological and neurophysiological changes in healthy adult humans across the age range (1993) (155)
Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomography. (1985) (151)
Genetic association of an (α2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease (1998) (150)
Memory, attention, and functional status in community-residing Alzheimer type dementia patients and optimally healthy aged individuals. (1984) (148)
Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. (2008) (144)
Disruptive behavior as a predictor in Alzheimer disease. (2007) (144)
Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. (2014) (140)
Cognitive performance in a high-functioning community-dwelling elderly population. (1993) (139)
Bayesian Parameter Estimation and Segmentation in the Multi-Atlas Random Orbit Model (2013) (136)
The clinical utility of the dementia rating scale for assessing Alzheimer patients. (1984) (132)
Changes in cognition (2011) (132)
Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative. (2000) (132)
Risk of death from Alzheimer's disease in a community population of older persons. (1991) (130)
Relation of smoking and alcohol consumption to incident Alzheimer's disease. (1992) (130)
Patterns of remote memory in amnesic and demented patients. (1981) (128)
Psychopathological Features in Alzheimer's Disease: Course and Relationship with Cognitive Status (2003) (127)
Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss (2010) (122)
Change in cognitive function in older persons from a community population: relation to age and Alzheimer disease. (1999) (121)
Relation of smoking and low-to-moderate alcohol consumption to change in cognitive function: a longitudinal study in a defined community of older persons. (1993) (121)
Self-efficacy beliefs and change in cognitive performance: MacArthur Studies of Successful Aging. (1996) (117)
Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiers (2017) (117)
MRI signatures of brain age and disease over the lifespan based on a deep brain network and 14 468 individuals worldwide. (2020) (117)
Correlates of objective and subjective measures of caregiver burden among dementia caregivers: influence of unmet patient and caregiver dementia-related care needs (2014) (117)
Psychiatric Symptomatology and Prodromal Alzheimer's Disease (2003) (116)
Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study. (2015) (113)
The absence of an apolipoprotein ϵ4 allele is associated with a more aggressive form of Alzheimer's disease (1997) (112)
Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease (2006) (111)
Structural Magnetic Resonance Imaging in Established and Prodromal Alzheimer Disease: A Review (2003) (109)
Perfusion abnormalities in prodromal AD (2000) (108)
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part III. Reliability of a standardized MRI evaluation of Alzheimer's disease (1992) (108)
Novel fearful faces activate the amygdala in healthy young and elderly adults (2006) (107)
Structural modeling of dynamic changes in memory and brain structure using longitudinal data from the normative aging study. (2004) (107)
Nonlinear changes in cognition with age and their neuropsychologic correlates. (1987) (106)
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects. (2015) (106)
Impact of differential attrition on the association of education with cognitive change over 20 years of follow-up: the ARIC neurocognitive study. (2014) (105)
The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. (2003) (105)
Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases (2012) (104)
Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype. (2014) (103)
Comparison of neurologic changes in 'successfully aging' persons vs the total aging population. (1994) (102)
Recall and recognition memory in obsessive-compulsive disorder. (1996) (101)
Association between the APOE genotype and psychopathologic symptoms in Alzheimer’s disease (2002) (101)
Ventricular size in patients with presenile dementia of the Alzheimer's type. (1984) (101)
DTI analyses and clinical applications in Alzheimer's disease. (2011) (100)
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture (2021) (99)
Perception of affect in patients with dementia of the Alzheimer type. (1991) (99)
African Americans and Clinical Research: Evidence Concerning Barriers and Facilitators to Participation and Recruitment Recommendations (2017) (98)
Health-care use and cost in dementia caregivers: Longitudinal results from the Predictors Caregiver Study (2015) (98)
Distinct pools of beta-amyloid in Alzheimer disease-affected brain: a clinicopathologic study. (2008) (98)
The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease. (2006) (97)
Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change. (2016) (96)
Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (96)
Inferring changepoint times of medial temporal lobe morphometric change in preclinical Alzheimer's disease (2014) (96)
Introduction to Revised Criteria for the Diagnosis of Alzheimer ’ s Disease : National Institute on Aging and the Alzheimer Association Workgroups (2011) (93)
Machine learning for comprehensive forecasting of Alzheimer’s Disease progression (2018) (92)
Longitudinal, region-specific course of diffusion tensor imaging measures in mild cognitive impairment and Alzheimer’s disease (2013) (92)
Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease (2017) (92)
Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia. (2019) (92)
CSF biomarker changes precede symptom onset of mild cognitive impairment (2013) (91)
Depressive Symptoms in Alzheimer's Disease: Natural Course and Temporal Relation to Function and Cognitive Status (2005) (91)
Interrelationships of peak expiratory flow rate with physical and cognitive function in the elderly: MacArthur Foundation studies of aging. (1995) (91)
Clinical Characteristics and Longitudinal Changes of Informal Cost of Alzheimer's Disease in the Community (2006) (89)
Multicenter Study of Predictors of Disease Course in Alzheimer Disease (the “Predictors Study”). I. Study Design, Cohort Description, and Intersite Comparisons (1993) (89)
MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD (2008) (89)
Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease (2015) (88)
Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. (2020) (86)
Alpha-2 macroglobulin in Alzheimer’s disease: a marker of neuronal injury through the RCAN1 pathway (2017) (86)
Emotion processing in the visual and auditory domains by patients with Alzheimer's disease (1999) (85)
Research consent for cognitively impaired adults: recommendations for institutional review boards and investigators. (2004) (85)
The pattern of age-related differences in electrophysiological activity of healthy males and females (1993) (83)
The ageing brain: normal and abnormal memory. (1997) (83)
The Fornix Sign: A Potential Sign for Alzheimer's Disease Based on Diffusion Tensor Imaging (2012) (83)
Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease. (2018) (82)
The effect of verbal mediators on the pictorial memory of brain-damaged patients (1983) (80)
Presenilin-1–associated abnormalities in regional cerebral perfusion (2001) (80)
Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin. (2003) (79)
A randomized feasibility pilot trial of hearing treatment for reducing cognitive decline: Results from the Aging and Cognitive Health Evaluation in Elders Pilot Study (2017) (78)
Statistical assessment of perceptual CT scan ratings in patients with Alzheimer type dementia. (1986) (76)
The diffeomorphometry of temporal lobe structures in preclinical Alzheimer's disease☆ (2013) (75)
Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years (2018) (75)
Effects of age upon interhemispheric EEG coherence in normal adults (1996) (74)
Patient Dependence and Longitudinal Changes in Costs of Care in Alzheimer’s Disease (2008) (74)
MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease. (2003) (74)
Inference of beliefs and emotions in patients with Alzheimer's disease. (2006) (73)
Development of remote memory loss in patients with Huntington's disease. (1981) (72)
Geriatric neuropsychology. (1981) (72)
The Association of Late-Life Diabetes Status and Hyperglycemia With Incident Mild Cognitive Impairment and Dementia: The ARIC Study (2019) (71)
Differences in abstraction ability with age. (1990) (71)
Evidence of Altered Posteromedial Cortical fMRI Activity in Subjects at Risk for Alzheimer Disease (2010) (70)
Extrapyramidal signs and other neurologic findings in clinically diagnosed Alzheimer's disease. A community-based study. (1993) (70)
Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns (2017) (69)
Characterization of 3 Novel Tau Radiopharmaceuticals, 11C-RO-963, 11C-RO-643, and 18F-RO-948, in Healthy Controls and in Alzheimer Subjects (2018) (69)
Self-Efficacy and Cognitive Performance in High-Functioning Older Individuals (1993) (69)
The Brain Chart of Aging: Machine‐learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans (2020) (68)
2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease (2014) (65)
Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer's disease (2013) (64)
Cognitive deficits in patients with chronic fatigue syndrome (1996) (64)
Relationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease (2013) (64)
Longitudinal assessment of patient dependence in Alzheimer disease. (2002) (64)
The Effects of Patient Function and Dependence on Costs of Care in Alzheimer's Disease (2008) (63)
An empirical study of diagnostic criteria for delirium. (1991) (63)
Hearing treatment for reducing cognitive decline: Design and methods of the Aging and Cognitive Health Evaluation in Elders randomized controlled trial (2018) (62)
Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts (2015) (62)
How does education affect cognitive function? (1995) (61)
Vision Impairment and Cognitive Outcomes in Older Adults: The Health ABC Study. (2018) (61)
A study of the efficacy of a comprehensive memory enhancement program in healthy elderly persons (1998) (61)
Diffusion tensor imaging of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's dementia. (2012) (61)
Use of Flutemetamol F 18–Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment (2018) (61)
Participation in clinical trials and long-term outcomes in Alzheimer's disease (1997) (61)
Quantitative Proteomic Profiling of Cerebrospinal Fluid to Identify Candidate Biomarkers for Alzheimer's Disease (2019) (60)
Development and Validation of a Structured Telephone Interview for Dementia Assessment (STIDA): The NIMH Genetics Initiative (1997) (60)
Time sequence diffeomorphic metric mapping and parallel transport track time-dependent shape changes (2009) (59)
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans (2012) (59)
Application of a growth curve approach to modeling the progression of Alzheimer's disease. (1996) (59)
Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease (2017) (58)
Single photon emission computed tomography perfusion differences in mild cognitive impairment (2006) (58)
ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes (2019) (56)
Cortical thickness in relation to clinical symptom onset in preclinical AD (2016) (56)
Longitudinal study of quality of life in people with advanced Alzheimer's disease. (2001) (56)
Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology (2020) (56)
An investigation of clinical correlates of Lewy bodies in autopsy-proven Alzheimer disease. (2001) (56)
Use of singular value decomposition to characterize age and gender differences in SPECT cerebral perfusion. (1998) (55)
Semantic processing in patients with Alzheimer's disease (1989) (55)
Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolism (2016) (55)
Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: the BIOCARD cohort (2015) (55)
Home Health and Informal Care Utilization and Costs Over Time in Alzheimer's Disease (2008) (54)
Inference of mental states in patients with Alzheimer's disease (2004) (54)
Change in body mass index before and after Alzheimer's disease onset. (2014) (53)
Application of Latent Variable Methods to the Study of Cognitive Decline When Tests Change over Time (2015) (51)
Dissociating Confidence and Accuracy: Functional Magnetic Resonance Imaging Shows Origins of the Subjective Memory Experience (2004) (51)
Sex differences in the genetic predictors of Alzheimer's pathology. (2019) (51)
Clinical features associated with costs in early AD (2006) (51)
Neuroimaging Correlates of Cerebral Microbleeds: The ARIC Study (Atherosclerosis Risk in Communities) (2017) (50)
Identifying Changepoints in Biomarkers During the Preclinical Phase of Alzheimer’s Disease (2019) (48)
Segmentation of brain magnetic resonance images based on multi-atlas likelihood fusion: testing using data with a broad range of anatomical and photometric profiles (2015) (48)
A standardized technique for establishing onset and duration of symptoms of Alzheimer's disease. (1995) (48)
Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort. (2012) (47)
Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia (2019) (47)
Multicenter Study of Predictors of Disease Course in Alzheimer Disease (the “Predictors Study”). II. Neurological, Psychiatric, and Demographic Influences on Baseline Measures of Disease Severity (1993) (45)
Cognitive reserve and cortical thickness in preclinical Alzheimer’s disease (2017) (45)
Network Neurodegeneration in Alzheimer’s Disease via MRI Based Shape Diffeomorphometry and High-Field Atlasing (2015) (44)
The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer disease. (2003) (44)
Processes underlying failures to recall remote events (1982) (44)
Neuropsychology of Alzheimer's disease. (2008) (44)
Age-related differences in computed tomographic scan measurements. (1988) (44)
Differential amygdala habituation to neutral faces in young and elderly adults (2005) (43)
Diffeomorphic Registration With Intensity Transformation and Missing Data: Application to 3D Digital Pathology of Alzheimer's Disease (2018) (43)
Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. (1998) (42)
Multi-Modal MRI Analysis with Disease-Specific Spatial Filtering: Initial Testing to Predict Mild Cognitive Impairment Patients Who Convert to Alzheimer’s Disease (2011) (42)
Relationship of cognitive reserve and APOE status to the emergence of clinical symptoms in preclinical Alzheimer’s disease (2013) (42)
Use of computerized CT analysis to discriminate between Alzheimer patients and normal control subjects. (1988) (41)
Cognitive differences between patients with progressive supranuclear palsy and Alzheimer's disease. (1989) (41)
Tools for multiple granularity analysis of brain MRI data for individualized image analysis (2014) (41)
Dementia and Alzheimer's Disease among Older Kidney Transplant Recipients. (2017) (40)
Sex-specific genetic predictors of Alzheimer’s disease biomarkers (2018) (40)
Neuropsychological Function in Patients With Chronic Fatigue Syndrome, Multiple Sclerosis, and Depression (2001) (40)
Modeling the influence of extrapyramidal signs on the progression of Alzheimer disease. (1996) (40)
CT density numbers in patients with senile dementia of the Alzheimer's type. (1984) (39)
Rarity of the Alzheimer disease-protective APP A673T variant in the United States. (2015) (39)
White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease (2019) (38)
Mild cognitive impairment and dementia. (2006) (38)
Using Deep Siamese Neural Networks for Detection of Brain Asymmetries Associated with Alzheimer's Disease and Mild Cognitive Impairment. (2019) (38)
Social cognition in Alzheimer's disease: A separate construct contributing to dependence (2014) (37)
Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease (2017) (36)
Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing (2018) (36)
Reliability and reproducibility of perfusion MRI in cognitively normal subjects. (2010) (36)
Variation in Variables that Predict Progression from MCI to AD Dementia over Duration of Follow-up. (2013) (35)
Neuropsychological predictors of dependency in patients with Alzheimer disease (2005) (35)
Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment. (2011) (35)
Assessment of cognitive function in the elderly. (1984) (35)
Memory for remote events in alcoholics. (1980) (34)
Large-scale genomics unveil polygenic architecture of human cortical surface area (2015) (34)
Unrestricted principal components analysis of brain electrical activity: Issues of data dimensionality, artifact, and utility (2005) (34)
Clinical correlates of Alzheimer's disease with and without silent radiographic abnormalities. (1995) (33)
Blood–Brain Barrier Breakdown in Relationship to Alzheimer and Vascular Disease (2021) (31)
Relationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults (2015) (31)
Lecithin (1987) (31)
Health indices as predictors of cognition among older African Americans: MacArthur studies of successful aging. (1997) (31)
Alzheimer's disease: implications of the updated diagnostic and research criteria. (2011) (30)
Electrophysiologic comparisons between two groups of patients with Alzheimer's disease. (1990) (30)
Quantified Neurophysiology with mapping: Statistical inference, Exploratory and Confirmatory data analysis (2005) (30)
Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease. (2020) (30)
Healthy brain aging: A meeting report from the Sylvan M. Cohen Annual Retreat of the University of Pennsylvania Institute on Aging (2008) (29)
Willingness to Be a Brain Donor: A Survey of Research Volunteers From 4 Racial/Ethnic Groups (2017) (29)
Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease (2017) (29)
Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits (2016) (28)
Comparison of costs of care between patients with Alzheimer's disease and dementia with Lewy bodies (2008) (28)
Delusions and patterns of cognitive impairment in Alzheimer's disease (1994) (27)
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
Quantitative proteomic analysis of the frontal cortex in Alzheimer’s disease (2020) (25)
Retinal signs and risk of incident dementia in the Atherosclerosis Risk in Communities study (2018) (25)
Temporoparietal electrophysiological differences characterize patients with Alzheimer's disease: a split-half replication study. (1995) (25)
NeurotechniqueWhole Brain Segmentation : Automated Labeling of Neuroanatomical Structures (2002) (25)
Blood glucose levels and cortical thinning in cognitively normal, middle-aged adults (2016) (25)
Erratum: Multicenter study of predictors of disease course in Alzheimer disease (the 'predictors study'). II. Neurological, psychiatric, and demographic influences on baseline measures of disease severity (Alzheimer Disease and Associated Disorders (1993) 7 (22-32)) (1993) (25)
Brain Oxygen Extraction Is Differentially Altered by Alzheimer's and Vascular Diseases (2020) (25)
A preliminary report: nutritional levels and cognitive performance in chronic alcohol abusers. (1982) (24)
Surface-Based Analysis on Shape and Fractional Anisotropy of White Matter Tracts in Alzheimer's Disease (2010) (24)
Retinal signs and 20-year cognitive decline in the Atherosclerosis Risk in Communities Study (2018) (24)
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols (2021) (24)
Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer's type: a double-blind placebo-controlled trial. (1990) (23)
Diabetes and cognitive outcomes in a nationally representative sample: the National Health and Aging Trends Study (2014) (23)
Cortical thickness atrophy in the transentorhinal cortex in mild cognitive impairment (2018) (23)
Clinicopathological correlates of depression in early Alzheimer's disease in the NACC (2016) (23)
A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium (2017) (22)
Entorhinal and transentorhinal atrophy in mild cognitive impairment using longitudinal diffeomorphometry (2017) (22)
Sequence of Alzheimer disease biomarker changes in cognitively normal adults (2020) (22)
18F-florbetapir Positron Emission Tomography–determined Cerebral &bgr;-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery (2018) (21)
Memory for remote events in chronic alcoholics and alcoholic Korsakoff patients. (1980) (21)
The relation of patient dependence to home health aide use in Alzheimer's disease. (2008) (21)
Benchmarks for designing two-stage studies using modified mini-mental state examinations: experience from the Women's Health Initiative Memory Study (2006) (21)
Exploring candidate gene associations with neuropsychological performance (2007) (21)
Resting-State Functional Connectivity Is Associated With Cerebrospinal Fluid Levels of the Synaptic Protein NPTX2 in Non-demented Older Adults (2019) (20)
'Alzheimer's Progression Score': Development of a Biomarker Summary Outcome for AD Prevention Trials. (2016) (20)
Multiplexed Phosphoproteomic Study of Brain in Patients with Alzheimer's Disease and Age-Matched Cognitively Healthy Controls. (2020) (20)
Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features (2017) (20)
Attitudes toward advance care planning among persons with dementia and their caregivers (2019) (20)
Cognitive Reserve from the Perspective of Preclinical Alzheimer Disease: 2020 Update. (2020) (20)
Alzheimer’s disease (2000) (20)
Plasma Markers of Inflammation Linked to Clinical Progression and Decline During Preclinical AD (2019) (20)
Organic implications of neuropsychological deficits in the elderly (2014) (20)
Early identification of Alzheimer's disease and related dementias. Agency for Health Care Policy and Research. (1996) (19)
CT Scan and Neuropsychological Relationships in Aging and Dementia (1986) (19)
Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals (2019) (19)
Phosphotyrosine profiling of human cerebrospinal fluid (2018) (19)
Evaluating Cognitive Reserve Through the Prism of Preclinical Alzheimer Disease. (2017) (19)
A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data (2019) (19)
Entorhinal and Transentorhinal Atrophy in Preclinical Alzheimer's Disease (2020) (19)
Combination therapy with lecithin and ergoloid mesylates for Alzheimer's disease. (1986) (18)
High Availability of the α7-Nicotinic Acetylcholine Receptor in Brains of Individuals with Mild Cognitive Impairment: A Pilot Study Using 18F-ASEM PET (2019) (18)
Evaluation of group-specific, whole-brain atlas generation using Volume-based Template Estimation (VTE): Application to normal and Alzheimer's populations (2014) (18)
The association between BOLD-based cerebrovascular reactivity (CVR) and end-tidal CO2 in healthy subjects (2019) (17)
Depressive symptoms in relation to clinical symptom onset of mild cognitive impairment (2018) (17)
Atlas-based diffusion tensor imaging correlates of executive function. (2015) (17)
Amygdala Atrophy in MCI/Alzheimer's Disease in the BIOCARD cohort based on Diffeomorphic Morphometry. (2012) (17)
Association of peripheral inflammatory markers with connectivity in large-scale functional brain networks of non-demented older adults (2020) (17)
Quantitative Susceptibility Mapping of Brain Iron and β-Amyloid in MRI and PET Relating to Cognitive Performance in Cognitively Normal Older Adults. (2020) (17)
Lethicin in the Treatment of Alzheimer's Disease (1983) (17)
Clinical impact of updated diagnostic and research criteria for Alzheimer's disease. (2011) (17)
Association of cerebrovascular reactivity and Alzheimer pathologic markers with cognitive performance (2020) (17)
Quantitative SPECT leads to improved performance in discrimination tasks related to prodromal Alzheimer's disease. (2004) (16)
Brain Oxygen Extraction by Using MRI in Older Individuals: Relationship to Apolipoprotein E Genotype and Amyloid Burden. (2019) (16)
Medical Image Harmonization Using Deep Learning Based Canonical Mapping: Toward Robust and Generalizable Learning in Imaging (2020) (16)
Changing Diagnostic Concepts of Alzheimer’s Disease (2012) (16)
Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (15)
Modeling age using cognitive, psychosocial and physiological variables: the Boston Normative Aging Study. (1991) (15)
Computerized Cognitive Tests Are Associated with Biomarkers of Alzheimer’s Disease in Cognitively Normal Individuals 10 Years Prior (2016) (15)
The healthy brain and our aging population: Translating science to public health practice (2007) (15)
Longitudinal association between diabetes and cognitive decline: The National Health and Aging Trends Study. (2017) (15)
Cerebrovascular reactivity mapping using intermittent breath modulation (2020) (15)
Aging, dementia and memory (1995) (15)
Association of midlife vascular risk and AD biomarkers with subsequent cognitive decline (2020) (15)
The Neuropsychology of the Development of Alzheimer’s Disease (2007) (15)
Alpha-2 macroglobulin in Alzheimer ' s disease : a marker of neuronal injury through the RCAN 1 pathway (15)
Neuroimaging in Alzheimer's disease. (1991) (14)
Fractional Segmentation of White Matter (1999) (14)
A new algorithm for predicting time to disease endpoints in Alzheimer's disease patients. (2013) (14)
Alzheimer's disease severity, objectively determined and measured (2016) (14)
Longitudinal Medication Usage in Alzheimer Disease Patients (2010) (14)
Comparison of patient and caregiver reports of patient activity participation and its relationship to mental health in patients with Alzheimer's disease. (2009) (13)
Cognitive Training for Ethnic Minority Older Adults in the United States: A Review (2018) (13)
Self-reported Lifestyle Activities in Relation to Longitudinal Cognitive Trajectories (2019) (13)
Reply to ‘Mechanisms underlying resilience in ageing’ (2019) (12)
Normal variations in brain oxygen extraction fraction are partly attributed to differences in end-tidal CO2 (2020) (12)
Assessment of cognition in advanced AD: The test for severe impairment (1999) (12)
Thyrotropin response to thyrotropin-releasing hormone in patients with dementia of the Alzheimer type (1993) (12)
CT and EEG validators for Alzheimer's disease. (1986) (12)
Cognitive reserve and midlife vascular risk: Cognitive and clinical outcomes (2020) (12)
Brain electrical correlates of psychological measures: Strategies and problems (2005) (12)
A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease (2016) (12)
Heart health meets cognitive health: evidence on the role of blood pressure (2021) (12)
Longitudinal decline in mild-to-moderate Alzheimer's disease: Analyses of placebo data from clinical trials (2016) (12)
PRECLINICAL PREDICTORS OF ALZHEIMER'S DISEASE (1997) (11)
Memory testing to improve the differential diagnosis of Alzheimer's disease. (1989) (11)
Knowledge of and Attitudes about Alzheimer Disease Genetics: Report of a Pilot Survey and Two Focus Groups (2007) (11)
The SIST-M: Predictive Validity of a Brief Structured Clinical Dementia Rating Interview (2012) (11)
Dementia in late-onset epilepsy (2020) (11)
Bridging from clinical endpoints to estimates of treatment value for external decision makers (2009) (11)
Prediction of rapid amyloid and phosphorylated‐Tau accumulation in cognitively healthy individuals (2020) (11)
AD risk score for the early phases of disease based on unsupervised machine learning (2020) (11)
Symmetrical and asymmetrical changes in brain tissue with age as measured on CT scans (1990) (10)
Normal and Abnormal Memory: Aging and Alzheimer's Disease (1998) (10)
Relationship Between Domain-Specific Cognitive Function and Speech-in-Noise Performance in Older Adults: The Atherosclerosis Risk in Communities Hearing Pilot Study. (2019) (10)
Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease. (2021) (10)
Lecithin in the treatment of Alzheimer's disease. (1983) (9)
Changing the trajectory of cognitive decline? (2007) (9)
Multi-atlas based detection and localization (MADL) for location-dependent quantification of white matter hyperintensities (2019) (9)
FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (2020) (9)
Utilization of Antihypertensives, Antidepressants, Antipsychotics, and Hormones in Alzheimer Disease (2011) (9)
Plasma Homovanillic Acid and Performance on Motor and Cognitive Tasks in Community-Dwelling Elderly: MacArthur Studies of Successful Aging (1994) (8)
The East Boston Alzheimer’s Disease Registry (1990) (8)
Gross feature recognition of Anatomical Images based on Atlas grid (GAIA): Incorporating the local discrepancy between an atlas and a target image to capture the features of anatomic brain MRI☆ (2013) (8)
Increased cerebral blood volume in small arterial vessels is a correlate of amyloid-β–related cognitive decline (2019) (8)
Cognitive Profiles of Normal Human Aging (1999) (8)
Relation of quantitative indexes of concurrent alpha-synuclein abnormalities to clinical outcome in autopsy-proven Alzheimer disease. (2006) (8)
The Structured Interview & Scoring Tool-Massachusetts Alzheimer's Disease Research Center (SIST-M): development, reliability, and cross-sectional validation of a brief structured clinical dementia rating interview. (2011) (8)
A PET study of age-related memory loss: The role of frontal cortex and hippocampus (1996) (7)
Two macroscopic and microscopic brain imaging studies of human hippocampus in early Alzheimer's disease and schizophrenia research (2004) (7)
Alternatives to amyloid for Alzheimer's disease therapies—a symposium report (2020) (7)
Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization (2021) (7)
Featured Articles Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (2011) (7)
19 : Recognition and Initial Assessment of Alzheimer ' s Disease and Related Dementias Clinical Practice Guideline (2010) (7)
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into the complex genetic architecture (2020) (7)
A harmonized longitudinal biomarkers and cognition database for assessing the natural history of preclinical Alzheimer's disease from young adulthood and for designing prevention trials (2019) (6)
The BIOCARD Index: A Summary Measure to Predict Onset of Mild Cognitive Impairment (2017) (6)
Detection of Very Early Alzheimer Disease Through Neuroimaging (2003) (6)
Author Correction: Maintenance, reserve and compensation: the cognitive neuroscience of healthy ageing (2018) (6)
Parallels between Down syndrome dementia and Alzheimer's disease. (1992) (6)
Medial temporal lobe white matter pathway variability is associated with individual differences in episodic memory in cognitively normal older adults (2019) (6)
The speed of constituent mental operations and its relationship to neuronal representation: An hypothesis (1991) (5)
Associations of actigraphic sleep and circadian rest/activity rhythms with cognition in the early phase of Alzheimer’s disease (2021) (5)
Disentangling Alzheimer’s disease neurodegeneration from typical brain ageing using machine learning (2021) (5)
Lecithin: absence of neurophysiologic effect in Alzheimer's disease by EEG topography. (1987) (5)
Extended multimodal whole-brain anatomical covariance analysis: detection of disrupted correlation networks related to amyloid deposition (2019) (4)
Alzheimer disease Cerebrospinal Fluid biomarker in Cognitively Normal Subjects : Multicenter 1 Study 2 (2015) (4)
Innovative approaches in cognitive aging (2019) (4)
Special behavioral paradigms in animals to study age-related changes in memory (1988) (4)
Brief Assessments of Cognitive Function in the Elderly (1994) (4)
Neuroethical Issues In Early Detection Of Alzheimer’S Disease (2011) (4)
Depressive symptoms and CSF Alzheimer's disease biomarkers in relation to clinical symptom onset of mild cognitive impairment (2020) (3)
Development of the achieve healthy aging study: A randomized controlled trial to determine if hearing loss treatment can reduce the risk of cognitive decline and dementia in older adults (2015) (3)
RESULTS FROM THE ACHIEVE-P STUDY: A PILOT STUDY FOR A RANDOMIZED CONTROLLED TRIAL TO DETERMINE IF HEARING LOSS TREATMENT CAN REDUCE THE RISK OF COGNITIVE DECLINE IN OLDER ADULTS (2016) (3)
Dissociating confidence and accuracy: fMRI shows origins of the subjective memory experience (2004) (3)
Ergot mesylates for alzheimer's disease: A year‐long double‐blind trial of 3 mg vs 12 mg daily (1990) (3)
Early Features of Alzheimer’s Disease (1999) (3)
MARKVCID PHASE II: PRIORITIZED CANDIDATE SMALL VESSEL VCID BIOMARKERS SELECTED FOR INDEPENDENT MULTI-SITE TESTING AND VALIDATION (2018) (3)
Alzheimer disease severity objectively determined and measured (2015) (3)
Relationship of CSF tau and ß-amyloid to hippocampal atrophy rates (2015) (3)
Computerized paired associate learning performance and imaging biomarkers in older adults without dementia (2021) (2)
Who, When, and How Common? (2009) (2)
Early detection of Alzheimer's disease using neuropsychological testing (2000) (2)
Erratum: Functional MRI detection of pharmacologically induced memory impairment (Proceedings of the National Academy of Sciences of the United States of America (January 8, 2002) 99:1 (455-460)) (2002) (2)
Automatic Statistical Identification of Neuroanatomical Abnormalities between Different Populations (2002) (2)
Using combinations of variables to identify individuals with preclinical ad (2015) (2)
Neuroanatomical Correlates of Cognitive and Neuropsychiatric Worsening in Alzheimer's Disease: Whole-Brain Longitudinal DTI Analysis (P03.092) (2012) (2)
Maintenance, reserve and compensation: the cognitive neuroscience of healthy ageing (2018) (2)
Abstract 98: Midlife Vascular Risk Factors and Incident Dementia in the ARIC Cohort (2017) (2)
Publisher Correction: Maintenance, reserve and compensation: the cognitive neuroscience of healthy ageing (2018) (2)
Tomm40/ApoE variation and age of onset of mild cognitive impairment and dementia in a prospective, longitudinal study (2015) (1)
Consultation corner. Redefining Alzheimer's disease. How new diagnostic criteria may speed up the search for a cure. (2011) (1)
Effects of lorazepam and scopolamine on encoding face-name associations: A pharmacologic fMRI trial (2001) (1)
Identifying Changepoints in Biomarkers During the Preclinical Phase of AD (2018) (1)
An fMRI investigation of memory-related medial temporal lobe activation in mild cognitive impairment prior to dementia (2005) (1)
Changes in pairwise functional connectivity associated with changes in cognitive performance in cognitively normal older individuals: A two-year observational study (2022) (1)
P3-090 MRI signal hyperintensities predict more rapid cognitive decline in Alzheimer's disease (AD) (2004) (1)
Longitudinal Association Between Diabetes and Cognitive Decline in a Nationally Representative Sample: The National Health and Aging Trends Study (2015) (1)
Segmentation of MRI brain scans into gray matter, white matter, and CSF (1997) (1)
Hearing loss and hearing care disparities among older adults with cognitive impairment (2020) (1)
Relationship of hearing impairment with MRI brain volumes and cognitive decline in the Atherosclerosis Risk in Communities study (2020) (1)
Assessment of memory loss. (1984) (1)
Shape analysis of hippocampus and amygdala in BIOCARD (2012) (1)
The Placebo Data Analysis in Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) Clinical Trials Project: Overview of progress in trial data collection, and key findings from the pooled Alzheimer's disease trial datasets (2013) (1)
Neuropsychology: Detection of dementia using rating scales and psychometric testing (1992) (1)
Policy Forum 2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease (2014) (1)
Heritability of regional brain volumes in large-scale neuroimaging and genetic studies (2017) (1)
Longitudinal medication usage in Alzheimer's disease patients (2009) (1)
from the Women's Health Initiative Memory Study Benchmarks for designing two-stage studies using modified mini-mental state examinations: experience (2013) (1)
NEUROPSYCHOLOGICAL ASSESSMENT IN THE DIFFERENTIAL DIAGNOSIS OF THE DEMENTIAS (1988) (1)
Longitudinal patterns of medication use in Alzheimer's disease (2010) (1)
Abstract 01: Diabetes is a Risk Factor for 20-year Cognitive Decline (2014) (1)
Clinical efficacy of low dose levetiracetam for hippocampal hyperactivity in amnestic mild cognitive impairment (2011) (1)
Change Point Estimation of the Hippocampal Volumes in Alzheimer's Disease (2016) (1)
Preclinical Prediction of AD: Relation Between Neuropsychological and Neuroimaging Findings (2002) (1)
The Absence of an Apolipoprotein E 4 Allele Is Associated with a More Aggressive Form of Alzheimer ' s Disease (2013) (1)
Accuracy of self‐ and proxy‐rated hearing among older adults with and without cognitive impairment (2021) (1)
Corrigendum: Vision Impairment and Cognitive Outcomes in Older Adults: The Health ABC Study. (2019) (1)
Ethics and the practice of brain science. (2002) (1)
WHITE MATTER HYPERINTENSITIES AND CSF BIOMARKERS IN RELATION TO CLINICAL SYMPTOM ONSET IN PRECLINICAL ALZHEIMER’S DISEASE (2018) (0)
On frontal lobe functions in the rat (1968) (0)
P3-100 Increased medial temporal lobe FMRI activation in questionable AD compared to normal aging (2004) (0)
Depression Severity in Relation to Clinical Symptom Onset in Mild Cognitive Impairment (2018) (0)
P1-214: Functional MRI of hippocampal subfields in healthy aging and mild cognitive impairment (2008) (0)
IC-P1-069: Functional MRI of hippocampal subfields in healthy aging and Mild Cognitive Impairment (2008) (0)
Care Planning for Individuals with Dementia Survey (2020) (0)
Test for Severe Impairment (2014) (0)
SEPARATING THE EARLIEST PHASE OF ALZHEIMER’S DISEASE FROM AGE-RELATED COGNITIVE DECLINE (2017) (0)
The Presence of Alzheimer's Disease in a Community Population-Reply (1990) (0)
045 Associations of Actigraphic Sleep and Circadian Rest/Activity Rhythms with Cognition in the Early Phase of Alzheimer’s Disease (2021) (0)
IC-P-071 The effect of APOE-4 on fMRI deactivation in older controls, MCI subjects and AD patients (2006) (0)
Abstract P237: Measuring Cognition in the Atherosclerosis Risk in Communities (ARIC) Study Cohort: An approach to Account for Informative Attrition (2015) (0)
VASCULAR RISK FACTORS AND CSF AD BIOMARKERS ARE INDEPENDENTLY ASSOCIATED WITH COGNITIVE DECLINE (2019) (0)
Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (2020) (0)
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease (2018) (0)
Medial temporal lobe changes preceding symptom onset of mild cognitive impairment: The BIOCARD Cohort (2013) (0)
Abstract 011: Retinal Signs Are Associated With Increased 20-Year Dementia Risk in the Atherosclerosis Risk in Communities Study (2018) (0)
Digging deeper into the vision-cognition relationship: Determining the association between visual function and cognitive domains (2019) (0)
PL3-01 Lifestyle factors & cognitive decline (2007) (0)
Neuropsychology and cognitive aging: What have we taught each other? (2000) (0)
COGNITIVE MEASURE MAY IDENTIFY ATROPHY IN BRAIN REGIONS ASSOCIATED WITH POSTERIOR CORTICAL ATROPHY (2017) (0)
Discriminant Analysis of Alzheimer's Disease-Reply (1994) (0)
Predictors of functional status in mild Alzheimer's disease (AD). (1993) (0)
31 Prediction of emerging amyloid and tau pathology in cognitively healthy individuals: a longitudinal CSF study (2019) (0)
Potential of ad biomarkers to reveal the presymptomatic disease process and the effects of treatments that may retard it (2015) (0)
1st Conference Clinical Trials on Alzheimer’s Disease September 17-18-19, 2008 School of Medecine Montpellier, France (2008) (0)
The association between cardiovascular risk and neurocognitive measures of executive function in at-risk, community-dwelling older adults: An fMRI study (2013) (0)
Delirium Symptom Interview (2015) (0)
O2-13-04 WHITE MATTER HYPERINTENSITIES AND CSF BIOMARKERS IN RELATION TO CLINICAL SYMPTOM ONSET IN PRECLINICAL ALZHEIMER’S DISEASE (2018) (0)
Abstract 94: Prevalence and Distinct Imaging Correlates of Deep Versus Lobar Cerebral Microbleeds: The Atherosclerosis Risk in Communities Study (2017) (0)
Orderings of biomarker changes for Alzheimer disease in cognitively normal individuals from 18 to 101 years of age (2020) (0)
Contemporary research criteria for dementia. (2018) (0)
Lessons to Be Learned about Clinical Trials in Preclinical AD from Ongoing Longitudinal Studies. (2015) (0)
DEVELOPMENT AND VALIDATION OF AN ALGORITHM FOR DIAGNOSING PRECLINICAL ALZHEIMER’S DISEASE ACROSS FIVE COHORTS (2016) (0)
P2-266 Greater cerebral atrophy predicts more rapid cognitive decline in Alzheimer’s disease (2006) (0)
CO2 cerebrovascular reactivity measured with phase‐contrast MRI: A potential biomarker of cognition and physical function in older adults (2020) (0)
Abstract P340: Prevalence of Cognitive Dysfunction Among Older Adults With Diabetes (2015) (0)
Clinical heterogeneity revisited: baseline findings of the Predictors Study. (1993) (0)
P4-142 THE SENSITIVITYAND SPECIFICITY OF THE CHINESE VERSION OFAD8 IN A NATIONWIDE SCREENING FOR DEMENTIA IN TAIWAN (2015) (0)
O2-07-05: Patient dependence, function, and changes in cost of care in Alzheimer's disease (2008) (0)
Delirium Symptom Interview (DSI) 1992 (2004) (0)
Structured Telephone Interview for Dementia Assessment (STIDA) (2015) (0)
Atlas-based quantification with machine-learning based characterization of DTI from patients with mild cognitive impairment and Alzheimer ’ s disease (2011) (0)
P2-240 Prediction of clinical stability vs. progression in questionable ad using perfusion spect (2004) (0)
Exploring genetic contributors to neuroprotection from AD pathologies: A genome‐wide association study (2020) (0)
P3-442: Comparison of costs of care between patients with Alzheimer's disease and dementia with Lewy bodies (2008) (0)
O2-07-04 A CROSS-CULTURAL QUALITATIVE STUDY OF BARRIERS AND FACILITATORS TO GOOD QUALITY CARE FOR PEOPLE WITH DEMENTIA (2008) (0)
REGIONAL WHITE MATTER HYPERINTENSITIES ARE DIFFERENTIALLY RELATED TO MEASURES OF VASCULAR RISK AND ALZHEIMER’S DISEASE (2018) (0)
Neurodegenerative Diseases: Clinical aspects of normal aging (2005) (0)
Invited Papers (1997) (0)
Development and implementation of the National Alzheimer's Prevention Registry (2013) (0)
Alzheimer's-signature MRI biomarker predicts likelihood of Alzheimer's dementia in cognitively normal adults (2011) (0)
Proposed alternative to the Talairach localization system (1997) (0)
Plasma ceramides predict hippocampal atrophy and progression in memory impairment among amnestic Mild Cognitive Impairment participants (2009) (0)
Author Correction: Maintenance, reserve and compensation: the cognitive neuroscience of healthy ageing (2018) (0)
DT-02-04 DETECTING BRAIN AMYLOID STATUS USING FULLYAUTOMATED PLASMA Ab BIOMARKER ASSAYS (2018) (0)
P1-057 Concepts of living things in patients with Alzheimer's disease (2004) (0)
Neuropsychological Assessment of Neuropsychiatric Disorders (1988) (0)
I'd Know that Face Anywhere. (1989) (0)
COGNITIVE RESERVE MITIGATES THE IMPACT OF HYPERTENSION ON COGNITIVE TRAJECTORIES (2019) (0)
, Professor of Neurologyc , Michel Goedert , Joint Headd , Miia Kivipelto , Professor and Director of Research , Head of Unit & Senior Geriatriciane (2015) (0)
Genetic associations with brain amyloidosis (2020) (0)
Serum ceramides predict incident Alzheimer's disease: The women's health and aging study (WHAS) II (2011) (0)
P2-073 Prediction of cognitive decline among very mild MCI cases (2006) (0)
P-048 Regionally-specific diffusion tensor imaging measures in Alzheimer’s disease and controls (2007) (0)
Title Large-scale genomics unveil polygenic architecture of human cortical surface area Permalink (2015) (0)
Body mass change in Alzheimer's disease (2013) (0)
S3-01-04 Imaging cognitive dysfunction (2006) (0)
IC-P-123 Greater cerebral atrophy predicts more rapid cognitive decline in Alzheimer’s disease (2006) (0)
Featured Article Longitudinal decline in mild-to-moderate Alzheimer's disease: Analyses of placebo data from clinical trials (2016) (0)
Invited Commentary: Senile Dementia (1981) (0)
The aging brain: morphology, imaging and function (2002) (0)
Cognitive measure may identify atrophy in visual brain regions associated with posterior cortical atrophy. (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Marilyn S. Albert?

Marilyn S. Albert is affiliated with the following schools:

Marilyn S. Albert's Academic­Influence.com Rankings

Marilyn S. Albert's Degrees

Why Is Marilyn S. Albert Influential?

Marilyn S. Albert's Published Works

Published Works

What Schools Are Affiliated With Marilyn S. Albert?

Marilyn S. Albert's AcademicInfluence.com Rankings